Lista de obras -

A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer ⬇️

artículo científico publicado el 2 de febrero de 2011

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial ⬇️

artículo científico publicado el 1 de marzo de 2012

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy

artículo científico publicado en 2004

Dislodgment of an inferior vena cava filter to the internal jugular vein ⬇️

artículo científico publicado el 1 de noviembre de 1997

Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer ⬇️

artículo científico publicado el 12 de julio de 2011

Empowering induction therapy for locally advanced head and neck cancer ⬇️

artículo científico publicado el 23 de septiembre de 2010

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

artículo científico publicado en 2003

Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure

artículo científico publicado en 2003

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples ⬇️

artículo científico publicado el 13 de abril de 2012

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

artículo científico publicado en 2004

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

artículo científico publicado en 2017

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies ⬇️

artículo científico publicado el 1 de septiembre de 2011

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck

artículo científico publicado en 2004

Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study ⬇️

artículo científico publicado el 27 de septiembre de 2011

Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review

artículo científico publicado en 2003

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

artículo científico publicado en 2005

Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302)

artículo científico publicado en 2020

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck ⬇️

artículo científico publicado el 7 de julio de 2011

Lista de obras de

A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer ⬇️

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial ⬇️

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy

Dislodgment of an inferior vena cava filter to the internal jugular vein ⬇️

Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer ⬇️

Empowering induction therapy for locally advanced head and neck cancer ⬇️

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples ⬇️

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies ⬇️

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck

Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study ⬇️

Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302)

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck ⬇️